Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CD138 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA547395
Description
In sandwich ELISAs, less than 0.3% cross-reactivity with recombinant human (rh) Syndecan-2, rhSyndecan-3, rhSyndecan-4, and recombinant mouse Syndecan-1 is observed. Reconstitute at 0.2 mg/mL in sterile PBS.
CD138 (syndecan 1) is a transmembrane proteoglycan that can bind a variety of cytokines and modulate their activity, as well as the activity of extracellular matrix components and influence many developmental processes. CD138 is expressed mainly in differentiating keratinocytes and is transiently upregulated in all layers of the epidermis upon tissue injury. It is also highly expressed on plasma cells and can be detected even on fibroblasts, vascular smooth muscle cells and endothelial cells. Up-regulation and down-regulation of CD138 on the cell surface often correlates with the gain of cancerous characteristics. Serum levels of the shedded soluble sCD138 are used as a prognostic factor of cancerogenesis.
Specifications
CD138 | |
Polyclonal | |
Unconjugated | |
Sdc1 | |
AA408134; AA409076; CD antigen 138; CD138; CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; HSPG; sCD138; SDC; Sdc1; soluble CD138; Sstn; syn-1; Synd; SYND1; Synd-1; SYNDECA; syndecan; syndecan 1; syndecan proteoglycan 1; Syndecan1; syndecan-1; synstatin | |
Goat | |
Antigen affinity chromatography | |
RUO | |
6382 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
ELISA, Immunohistochemistry (Paraffin), Western Blot | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
P18827 | |
Sdc1 | |
Mouse myeloma cell line NS0-derived recombinant human Syndecan-1/CD138 Gln18-Glu251. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction